Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis Kim

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Disease Models & Mechanisms|December 19, 2008
Studying host-pathogen interactions and innate immunity in Caenorhabditis elegansDennis Kim
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 28, 2007
Delayed-type hypersensitivity reaction to the meta-cresol component of insulinDennis Kim, James Baraniuk
The World Allergy Organization Journal|December 27, 2012
Dermatology for the allergistDennis Kim, Richard Lockey
Current Opinion in Otolaryngology & Head and Neck Surgery|July 11, 2007
Neural aspects of allergic rhinitisDennis Kim, James N Baraniuk
Current Allergy and Asthma Reports|April 18, 2007
Sensing the air around us: the voltage-gated-like ion channel familyDennis Kim, James N Baraniuk
Current Allergy and Asthma Reports|April 18, 2007
Nasonasal reflexes, the nasal cycle, and sneezeJames N Baraniuk, Dennis Kim
Expert Opinion on Drug Metabolism & Toxicology|July 22, 2009
Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthmaDennis Kim, Mark Glaum, Richard Lockey
Urology|April 3, 2003
Aspiration and sclerotherapy versus hydrocelectomy for treatment of hydrocelesDarren T Beiko, Dennis Kim, Alvaro Morales
Diabetes Technology & Therapeutics|June 28, 2006
Incretin mimetics and dipeptidyl peptidase-IV inhibitors: a review of emerging therapies for type 2 diabetesDavid M Kendall, Dennis Kim, David Maggs
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 13, 2002
Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitusAlain D Baron, Dennis Kim, Christian Weyer
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Disease Models & Mechanisms|December 19, 2008
Studying host-pathogen interactions and innate immunity in Caenorhabditis elegansDennis Kim
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 28, 2007
Delayed-type hypersensitivity reaction to the meta-cresol component of insulinDennis Kim, James Baraniuk
The World Allergy Organization Journal|December 27, 2012
Dermatology for the allergistDennis Kim, Richard Lockey
Current Opinion in Otolaryngology & Head and Neck Surgery|July 11, 2007
Neural aspects of allergic rhinitisDennis Kim, James N Baraniuk
Current Allergy and Asthma Reports|April 18, 2007
Sensing the air around us: the voltage-gated-like ion channel familyDennis Kim, James N Baraniuk
Current Allergy and Asthma Reports|April 18, 2007
Nasonasal reflexes, the nasal cycle, and sneezeJames N Baraniuk, Dennis Kim
Expert Opinion on Drug Metabolism & Toxicology|July 22, 2009
Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthmaDennis Kim, Mark Glaum, Richard Lockey
Urology|April 3, 2003
Aspiration and sclerotherapy versus hydrocelectomy for treatment of hydrocelesDarren T Beiko, Dennis Kim, Alvaro Morales
Diabetes Technology & Therapeutics|June 28, 2006
Incretin mimetics and dipeptidyl peptidase-IV inhibitors: a review of emerging therapies for type 2 diabetesDavid M Kendall, Dennis Kim, David Maggs
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 13, 2002
Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitusAlain D Baron, Dennis Kim, Christian Weyer
Pageof 16